Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.42 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.42 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.42 |
| ▸ | TTR | P02766 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | NSD2 | O96028 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25745 | 1.00 | CA12 (0.44) | CA12CA9CA4CA7CA14 | |
| SCHEMBL29358898 | 1.00 | CA12 (0.44) | CA12CA9CA4CA7CA14 | |
| SCHEMBL134374 | 0.88 | CA12 (0.47) | CA12CA9CA4CA7CA14 | |
| SCHEMBL9626308 | 0.87 | CA12 (0.44) | CA12CA9CA4CA7CA14 | |
| SCHEMBL21347987 | 0.87 | CA12 (0.47) | CA12CA9CA4CA7CA14 | |
| SCHEMBL21347989 | 0.87 | CA12 (0.47) | CA12CA9CA4CA7CA14 | |
| SCHEMBL22793508 | 0.86 | TTR (0.43) | CA12CA9CA4CA7CA14 | |
| SCHEMBL7813627 | 0.85 | PRKAG1 (0.39) | CA12CA9CA4CA7CA14 | |
| SCHEMBL6128009 | 0.84 | CA12 (0.63) | CA12CA9CA4CA7CA14 | |
| SCHEMBL3036841 | 0.83 | TTR (0.49) | CA12CA9CA4CA7CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 656 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023164252-A1 | ISOTHERMAL NUCLEIC ACID DETECTION ASSAYS AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-08-31 | — | — | WO | claimed |
| EP-4097244-A2 | RAPID DETECTION TEST FOR SARS-COV-2 | NLC Pharma Ltd (IL) | 2022-12-07 | — | — | EP | claimed |
| CN-115335532-A | SARS-COV-2 quick detection test | NLC制药有限公司 | 2022-11-11 | — | — | CN | claimed |
| US-20260146281-A1 | METHODS AND COMPOSITIONS FOR MULTIMODAL IN SITU ANALYSIS | 10X GENOMICS, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| CN-122095084-A | Antigen-specific T cell receptors and chimeric antigen receptors and methods of use in modulation of immune signaling for cancer immunotherapy | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260139300-A1 | NUCLEIC ACID CONCATEMERS AND METHODS FOR STABILIZING AND/OR COMPACTING THE SAME | 10X GENOMICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| WO-2026107198-A1 | ANTIBODY BIOMARKER TO DIAGNOSE IDIOPATHIC INFLAMMATORY MYOPATHIES | OHIO STATE INNOVATION FOUNDATION (US) | 2026-05-21 | — | — | WO | disclosed |
| US-20260139301-A1 | CATALYTIC DE-CROSSLINKING OF SAMPLES FOR IN SITU ANALYSIS | 10X GENOMICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| WO-2026102257-A2 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID AMPLIFICATION | TRACERDX, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| US-20260132451-A1 | RESOLVING SPATIAL ARRAYS BY PROXIMITY-BASED DECONVOLUTION | 10X GENOMICS, INC. (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4741513-A2 | METHODS AND COMPOSITIONS FOR SYNCHRONIZING REACTIONS IN SITU | 10X Genomics, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20220049293-A1 | METHODS FOR DETERMINING A LOCATION OF A BIOLOGICAL ANALYTE IN A BIOLOGICAL SAMPLE | 10X GENOMICS, INC. (US) | 2022-02-17 | — | — | US | disclosed |
| US-20220049294-A1 | IMAGING SYSTEM HARDWARE | 10X GENOMICS, INC. (US) | 2022-02-17 | — | — | US | disclosed |
| US-20220042915-A1 | DEVICE AND METHODS FOR QUANTIFYING ANALYTES INTRODUCTION | INVITROGEN CORPORATION | 2022-02-10 | — | — | US | disclosed |
| WO-2021263211-A9 | ANTIGEN-SPECIFIC T CELL RECEPTORS AND CHIMERIC ANTIGEN RECEPTORS, AND METHODS OF USE IN IMMUNE SIGNALING MODULATION FOR CANCER IMMUNOTHERAPY | Houston Methodist Hospital (US) | 2022-02-03 | — | — | WO | disclosed |
| US-20220033888-A1 | GENERATING CAPTURE PROBES FOR SPATIAL ANALYSIS | 10X GENOMICS, INC. (US) | 2022-02-03 | — | — | US | disclosed |
| US-11236149-B2 | Microbe-binding molecules and uses thereof | PRESIDENT AND FALLOWS OF HARVARD COLLEGE (US) | 2022-02-01 | — | — | US | disclosed |
| CN-113994001-A | Imaging-based hybrid CRISPR screening | 哈佛学院院长及董事 | 2022-01-28 | — | — | CN | disclosed |
| US-20220025446-A1 | METHODS OF USING MASTER / COPY ARRAYS FOR SPATIAL DETECTION | 10X GENOMICS, INC. (US) | 2022-01-27 | — | — | US | disclosed |
| EP-3942281-A1 | MULTI-FUNCTION ANALYTIC DEVICES | Biomeme, Inc. (US) | 2022-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139300-A1 | NUCLEIC ACID CONCATEMERS AND METHODS FOR STABILIZING AND/OR COMPACTING THE SAME | INCENP, SLIRP, SMCHD1 | CA12 373/4885CA9 1191/4885CA4 645/4885 |
| US-20260146281-A1 | METHODS AND COMPOSITIONS FOR MULTIMODAL IN SITU ANALYSIS | BRCA1, MKI67, STAT3 | CA12 87/4885CA9 161/4885CA4 209/4885 |
| US-20260139301-A1 | CATALYTIC DE-CROSSLINKING OF SAMPLES FOR IN SITU ANALYSIS | RNGTT, NSUN2, POLL | CA12 87/4885CA9 93/4885CA4 46/4885 |
| US-20260132451-A1 | RESOLVING SPATIAL ARRAYS BY PROXIMITY-BASED DECONVOLUTION | RNGTT, ADAR, CPSF1 | CA12 914/4885CA9 1793/4885CA4 2331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.